Repeat colonoscopies not always beneficial for some patients

This article originally appeared here.
Low Yield for Repeat Colonoscopy in Some Patients
Low Yield for Repeat Colonoscopy in Some Patients

(HealthDay News) -- Repeat colonoscopies within 10 years are of little benefit to patients who had no polyps found on adequate examination; however, repeat colonoscopies do benefit patients when the baseline examination was compromised, according to research published in the August issue of Gastroenterology.

David A. Lieberman, M.D., of the Oregon Health and Science University in Portland, and colleagues analyzed data for 17,525 asymptomatic patients who were found to have no polyps during a screening colonoscopy and received another colonoscopy within 10 years.

The researchers found that repeat colonoscopy within one year, typically done because of inadequate bowel preparation or incomplete exam for the baseline colonoscopy, showed a prevalence of large polyps (>9 mm) of 6.5 percent (95 percent confidence interval [CI], 5.3 to 7.6 percent). This prevalence is similar to the rate found in the average-risk screening population. Among patients with an adequate baseline examination, the incidence of large polyps upon repeat colonoscopy was 3.1 percent (95 percent CI, 2.7 to 3.5 percent) within one to five years and 3.7 percent (95 percent CI, 3.3 to 4.1 percent) within five to 10 years.

"In light of the maturing body of evidence about the strong influence of sex, race/ethnicity, and other factors (e.g., tobacco, alcohol, diet) on the risk of neoplasia, individualized risk-based screening and surveillance algorithms should be developed," write the authors of an accompanying editorial.

The practice network has received funding from pharmaceutical and biomedical companies.

Abstract
Full Text

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs